SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-075657
Filing Date
2024-06-27
Accepted
2024-06-27 16:10:06
Documents
2
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2418363-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2418363-1_3seq1.xml 3 9754
2 EXHIBIT 24 tm2418363d1_ex24.htm EX-24 7446
  Complete submission text file 0001104659-24-075657.txt   19080
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACTINIUM PHARMACEUTICALS, INC 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address
CICIC DRAGAN (Reporting) CIK: 0001565795 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33958 | Film No.: 241079249